Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
Abstract
Share and Cite
Huang, J.; Teng, X. Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Curr. Oncol. 2020, 27, 656-663. https://doi.org/10.3747/co.27.6437
Huang J, Teng X. Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Current Oncology. 2020; 27(6):656-663. https://doi.org/10.3747/co.27.6437
Chicago/Turabian StyleHuang, J., and Xiaodong Teng. 2020. "Expression of PD-L1 for Predicting Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis" Current Oncology 27, no. 6: 656-663. https://doi.org/10.3747/co.27.6437